2019 Statutory Scheme

Executive Summary

Branded medicines sold to the NHS must be provided under one of two schemes. The first is the Voluntary Scheme for Branded Medicines Pricing and Access, which was agreed between DHSC, NHSE, and ABPI. Any companies which are not members of this scheme will sell their branded medicines under the Statutory Scheme. Both of these schemes are successors to previous arrangements which have been overhauled by DHSC over the course of 2018 and came into force at the beginning of 2019.